Clinical Report: R-spondin 3 Enhances Immunogenicity in Gastric Adenocarcinoma

Overview

This study investigates the role of R-spondin 3 (RSPO3) in enhancing immunogenicity and adaptive immune resistance in human gastric adenocarcinoma. The findings suggest that RSPO3 levels correlate with leukocyte infiltration and immune checkpoint signaling.

Background

Gastric cancer is a leading cause of cancer-related mortality worldwide, with many patients diagnosed at advanced stages. The heterogeneous immune landscape of gastric cancer complicates treatment, as established biomarkers do not fully predict therapeutic responses. Understanding the role of RSPO3 in gastric carcinogenesis is important for clarifying mechanisms involved in gastric cancer.

Data Highlights

No numerical data or trial data provided in the source material.

Key Findings

• RSPO3 enhances Wnt signaling via LGR4 and LGR5 receptors.
• RSPO3 levels correlate with leukocyte infiltration in gastric adenocarcinoma.
• Dysregulated Wnt signaling is present in approximately 50% of human gastric cancers.
• Immunotherapy response rates are influenced by tumor-infiltrating lymphocytes.
• Current biomarkers like PD-L1 expression predict therapeutic benefit incompletely.

Clinical Implications

The correlation between RSPO3 levels and immune checkpoint signaling may inform biomarker development for predicting treatment responses in gastric cancer.

Conclusion

The study highlights the role of RSPO3 in the immune landscape of gastric adenocarcinoma.

Related Resources & Content

1. Author(s)/Org, Source, Year -- Title
2. Author(s)/Org, Source, Year -- Title
3. Author(s)/Org, Source, Year -- Title
4. Author(s)/Org, Source, Year -- Title
5. Author(s)/Org, Source, Year -- Title
6. Author(s)/Org, Source, Year -- Title
7. Author(s)/Org, Source, Year -- Title
8. Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline Update | Journal of Clinical Oncology
9. Gastric Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology - PubMed
10. Wnt signaling in gastric cancer: current progress and future prospects - PMC